EBNA1 and LMP1 variants in multiple sclerosis cases and controls
- 15 July 2010
- journal article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 124 (1), 53-58
- https://doi.org/10.1111/j.1600-0404.2010.01410.x
Abstract
Simon KC, Yang X, Munger KL, Ascherio A. EBNA1 and LMP1 variants in multiple sclerosis cases and controls.Acta Neurol Scand: 2011: 124: 53–58.© 2010 John Wiley & Sons A/S. Background – Prior infection with Epstein–Barr virus (EBV) is an established risk factor for multiple sclerosis (MS). Some findings from observational studies, including possible epidemics and differences in prevalence, may be explained if different strains of EBV conferred different MS risk. Methods – DNA was extracted from peripheral lymphocytes obtained from 66 MS cases and 66 age‐ and cohort‐matched controls. Nested polymerase chain reaction (PCR) was performed to amplify the N‐ and C‐terminus regions of EBNA1 and the hyper‐variable region of the LMP1 gene. For EBNA1, we compared the presence of the prototype B95.8 vs variant sequence and the presence of multiple strains in MS cases and controls. For LMP1, we considered differences in the proportions of mutations between cases and controls. Results – Comparing the proportion of mutant sequence between MS cases and controls in the EBNA1 N‐terminal (0/28 vs 1/27) and C‐terminal regions (3/40 vs 8/36) revealed no significant differences (P > 0.05). No individual variants in LMP1 were associated with risk of MS (all P > 0.05). Neither EBNA1 nor LMP1 variation was associated with anti‐EBNA1 IgG antibody titers. Conclusions – These findings do not support a strong role for variation in EBNA1 N‐terminus, EBNA1 C‐terminus or LMP1 contributing to MS risk.Keywords
This publication has 30 references indexed in Scilit:
- The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: A need for reappraisalVirus Research, 2009
- Tumor-derived Variants of Epstein-Barr Virus Latent Membrane Protein 1 Induce Sustained Erk Activation and c-FosJournal of Biological Chemistry, 2008
- Structural variability of the carboxy‐terminus of Epstein–Barr virus encoded latent membrane protein 1 gene in Hodgkin's lymphomasJournal of Medical Virology, 2007
- Epstein?Barr virus genotypes in multiple sclerosisActa Neurologica Scandinavica, 2007
- Multiple Epstein‐Barr Virus Strains in Patients with Infectious Mononucleosis: Comparison of Ex Vivo Samples with In Vitro Isolates by Use of Heteroduplex Tracking AssaysThe Journal of Infectious Diseases, 2006
- Multiple Epstein-Barr Virus Infections in Healthy IndividualsJournal of Virology, 2003
- Carboxy Terminal Variants of Epstein‐Barr Virus–Encoded Latent Membrane Protein 1 during Long‐Term Human Immunodeficiency Virus Infection: Reliable Markers for Individual Strain IdentificationThe Journal of Infectious Diseases, 1999
- Paediatric Hodgkin's disease in Spain: association with Epstein‐Barr virus strains carrying latent membrane protein‐1 oncogene deletions and high frequency of dual infectionsBritish Journal of Haematology, 1998
- Sequence variation in the Epstein--Barr virus latent membrane protein 1Journal of General Virology, 1994
- Disease-related differences in antibody patterns against EBV-encoded nuclear antigens EBNA 1, EBNA 2 and EBNA 6European Journal Of Cancer, 1993